MSN Labs inks pact with Eli Lilly to make, market COVID drug Baricitinib
MSN Labs inks pact with Eli Lilly to make, market COVID drug Baricitinib.....»»
Natco Pharma signs pact with Eli Lilly for Baricitinib
Natco Pharma signs pact with Eli Lilly for Baricitinib.....»»
Glenmark inks pact with SaNOtize to produce, market anti-COVID-19 nasal spray in India, other countries
Glenmark inks pact with SaNOtize to produce, market anti-COVID-19 nasal spray in India, other countries.....»»
Laurus Labs gets DRDO licence to make anti-COVID drug 2DG
Laurus Labs gets DRDO licence to make anti-COVID drug 2DG.....»»
Dr. Reddy"s Labs to launch Covid drug 2-DG at Rs 990 per sachet
Dr. Reddy"s Labs to launch Covid drug 2-DG at Rs 990 per sachet.....»»
BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG
BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG.....»»
BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG
BDR Pharma inks license agreement with DRDO to produce Covid drug 2-DG.....»»
Dr Reddy"s Laboratories announces commercial launch of Covid-19 drug 2-DG
Dr Reddy"s Laboratories announces commercial launch of Covid-19 drug 2-DG.....»»
Nepal inks $150-mn loan pact with World Bank for post-Covid growth
Nepal inks $150-mn loan pact with World Bank for post-Covid growth.....»»
Dr Reddy"s developing new treatment options for Covid-19, says MD
Dr Reddy"s developing new treatment options for Covid-19, says MD.....»»
BDR Pharma ties up Eli Lilly for COVID-19 drug
BDR Pharma ties up Eli Lilly for COVID-19 drug.....»»
BDR Pharma ties up Eli Lilly for COVID-19 drug
BDR Pharma ties up Eli Lilly for COVID-19 drug.....»»
Torrent Pharma in a license agreement with Eli Lilly for baricitinib to treat Covid-19; Stock gains 1%
Torrent Pharma in a license agreement with Eli Lilly for baricitinib to treat Covid-19; Stock gains 1%.....»»
Vivimed Labs bags Govt nod to manufacture, market Favipiravir tablets for Covid treatment in India
Vivimed Labs bags Govt nod to manufacture, market Favipiravir tablets for Covid treatment in India.....»»
Lupin enters into a license agreement with Eli Lilly for manufacturing Baricitinib in India to treat Covid
Lupin enters into a license agreement with Eli Lilly for manufacturing Baricitinib in India to treat Covid.....»»
MSD ties up with 5 Indian pharma majors for supply of oral COVID-19 drug Molnupiravir
MSD ties up with 5 Indian pharma majors for supply of oral COVID-19 drug Molnupiravir.....»»
Farmers plead with Centre not to double cess on tobacco
Farmers plead with Centre not to double cess on tobacco.....»»
20-30% new products may be under USFDA lens
20-30% new products may be under USFDA lens.....»»
Tata Steel says India export tax could alter output targets
Tata Steel says India export tax could alter output targets.....»»
F&O expiry, 3 IPO listings among key factors that will steer market this week
F&O expiry, 3 IPO listings among key factors that will steer market this week.....»»
Bommai’s third visit to Delhi, this time to ask for more Covid vaccines
Bommai’s third visit to Delhi, this time to ask for more Covid vaccines.....»»